Further evidence to support the individualised treatment of gonorrhoea with ciprofloxacin.
UQ Centre for Clinical Research, University of Queensland, Brisbane, QLD 4029, Australia. Electronic address: e.trembizki@uq.edu.au.
Ella
E
Trembizki
Kirby Institute, UNSW Australia, Sydney, NSW, Australia.
Rebecca
R
Guy
Kirby Institute, UNSW Australia, Sydney, NSW, Australia.
Basil
B
Donovan
Kirby Institute, UNSW Australia, Sydney, NSW, Australia.
John M
JM
Kaldor
WHO Collaborating Centre for STD, Microbiology Department, South Eastern Area Laboratory Services, Prince of Wales Hospital, Sydney, NSW, Australia; School of Medical Sciences, Faculty of Medicine, UNSW Australia, Sydney, NSW, Australia.
Monica M
MM
Lahra
UQ Centre for Clinical Research, University of Queensland, Brisbane, QLD 4029, Australia; Pathology Queensland Central Laboratory, Brisbane, QLD, Australia.
David M
DM
Whiley
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001315:Australia / Q000453:epidemiology; D002939:Ciprofloxacin / Q000627:therapeutic use*; D027081:DNA Gyrase / Q000235:genetics; D024901:Drug Resistance, Multiple, Bacterial; D006069:Gonorrhea / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D006801:Humans; D009344:Neisseria gonorrhoeae / Q000187:drug effects* / Q000235:genetics; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D027081:DNA Gyrase